Skip to main content
Erschienen in: Calcified Tissue International 1/2010

01.01.2010

Strontium Ranelate Enhances Callus Strength More Than PTH 1-34 in an Osteoporotic Rat Model of Fracture Healing

verfasst von: Bjoern Habermann, Konstantinos Kafchitsas, Gavin Olender, Peter Augat, Andreas Kurth

Erschienen in: Calcified Tissue International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Treatment of an underlying disease is often initiated after the occurrence of an osteoporotic fracture. Our aim was to investigate whether teriparatide (PTH 1-34) and strontium ranelate affect fracture healing in ovariectomized (OVX) rats when provided for the first time after the occurrence of an osteoporotic fracture. We combined the model of an OVX rat with a closed diaphyseal fracture. Sixty Sprague Dawley rats were randomly assigned to four groups. Fracture healing in OVX rats after treatment with pharmacological doses of strontium ranelate and PTH 1-34 was compared with OVX and sham-treated control groups. After 28 days, the femur was excised and scanned by micro computed tomography and the callus evaluated, after which biomechanical torsional testing was performed and torque and toughness until reaching the yield point were analyzed. Only treatment with strontium ranelate led to a significant increase in callus resistance compared to the OVX control rats, whereas both PTH 1-34 and strontium ranelate increased the bone volume/tissue volume ratio of the callus. The PTH 1-34–increased trabecular bone volume within the callus was even higher compared to sham. As for the callus tissue volume, the increase induced by strontium ranelate was significant, contrary to the changes induced by PTH. Callus in strontium ranelate–treated animals is more resistant to torsion compared with OVX control rats. To our knowledge, this is the first report of the enhancement of fracture healing by strontium ranelate. Because both treatments enhance bone and tissue volume within the callus, there may be a qualitative difference between the calluses of PTH 1-34– and strontium ranelate–treated OVX rats. The superior results obtained with strontium ranelate compared to PTH in terms of callus resistance could be the consequence of a better quality of the new bone formed within the callus.
Literatur
1.
Zurück zum Zitat Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822CrossRefPubMed Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822CrossRefPubMed
2.
Zurück zum Zitat Meunier PF, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468CrossRefPubMed Meunier PF, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459–468CrossRefPubMed
3.
Zurück zum Zitat Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ (2006) Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21:536–542CrossRefPubMed Roux C, Reginster JY, Fechtenbaum J, Kolta S, Sawicki A, Tulassay Z, Luisetto G, Padrino JM, Doyle D, Prince R, Fardellone P, Sorensen OH, Meunier PJ (2006) Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors. J Bone Miner Res 21:536–542CrossRefPubMed
4.
Zurück zum Zitat Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY (2009) Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 20:1663–1673CrossRefPubMed Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY (2009) Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 20:1663–1673CrossRefPubMed
5.
Zurück zum Zitat Réginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP (2009) Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone 45:1059–1064CrossRefPubMed Réginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP (2009) Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Bone 45:1059–1064CrossRefPubMed
6.
Zurück zum Zitat Marie PJ (2005) Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos Int 16(suppl 1):S7–S10CrossRefPubMed Marie PJ (2005) Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporos Int 16(suppl 1):S7–S10CrossRefPubMed
7.
Zurück zum Zitat Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38:S10–S14CrossRefPubMed Marie PJ (2006) Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 38:S10–S14CrossRefPubMed
8.
Zurück zum Zitat Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517–523CrossRefPubMed Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ (1996) The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18:517–523CrossRefPubMed
9.
Zurück zum Zitat Zhu LL, Zaidi S, Peng Y, Zhou H, Moonga BS, Blesius A, Dupin-Roger I, Zaidi M, Sun L (2007) Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355:307–311CrossRefPubMed Zhu LL, Zaidi S, Peng Y, Zhou H, Moonga BS, Blesius A, Dupin-Roger I, Zaidi M, Sun L (2007) Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355:307–311CrossRefPubMed
10.
Zurück zum Zitat Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42:129–138CrossRefPubMed Bonnelye E, Chabadel A, Saltel F, Jurdic P (2008) Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42:129–138CrossRefPubMed
11.
Zurück zum Zitat Baron R, Tsouderos Y (2002) In vitro effects of S12911–2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450:11–17CrossRefPubMed Baron R, Tsouderos Y (2002) In vitro effects of S12911–2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 450:11–17CrossRefPubMed
12.
Zurück zum Zitat Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S 12911–2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18:1082–1087CrossRefPubMed Takahashi N, Sasaki T, Tsouderos Y, Suda T (2003) S 12911–2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 18:1082–1087CrossRefPubMed
13.
Zurück zum Zitat Hurtel AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM, Brazier M (2008) The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis: new insights into the associated signalling pathways. J Biol Chem 284:575–584CrossRef Hurtel AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM, Brazier M (2008) The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis: new insights into the associated signalling pathways. J Biol Chem 284:575–584CrossRef
14.
Zurück zum Zitat Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419–1425CrossRefPubMed Ammann P, Badoud I, Barraud S, Dayer R, Rizzoli R (2007) Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 22:1419–1425CrossRefPubMed
15.
Zurück zum Zitat Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P (2009) Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 20:1417–1428CrossRefPubMed Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P (2009) Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 20:1417–1428CrossRefPubMed
16.
Zurück zum Zitat Ejersted C, Andreassen TT, Oxlund H, Jørgensen PH, Bak B, Häggblad J, Tørring O, Nilsson MHL (1993) Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097–1101PubMedCrossRef Ejersted C, Andreassen TT, Oxlund H, Jørgensen PH, Bak B, Häggblad J, Tørring O, Nilsson MHL (1993) Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097–1101PubMedCrossRef
17.
Zurück zum Zitat Wronski TJ, Yen CF, Qi H, Dann LM (1993) Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823–831CrossRefPubMed Wronski TJ, Yen CF, Qi H, Dann LM (1993) Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823–831CrossRefPubMed
18.
Zurück zum Zitat Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ (1995) The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strengthassessed in a sexually mature, ovariectomized rat model. Bone 16:223–230CrossRefPubMed Mosekilde L, Danielsen CC, Søgaard CH, McOsker JE, Wronski TJ (1995) The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strengthassessed in a sexually mature, ovariectomized rat model. Bone 16:223–230CrossRefPubMed
19.
Zurück zum Zitat Andreassen TT, Oxlund H (2000) The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J Bone Miner Res 15:2266–2275CrossRefPubMed Andreassen TT, Oxlund H (2000) The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J Bone Miner Res 15:2266–2275CrossRefPubMed
20.
Zurück zum Zitat Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRefPubMed Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441CrossRefPubMed
21.
Zurück zum Zitat Skripitz R, Aspenberg P (2004) Parathyroid hormone—a drug for orthopedic surgery? Acta Orthop Scand 75:654–662PubMed Skripitz R, Aspenberg P (2004) Parathyroid hormone—a drug for orthopedic surgery? Acta Orthop Scand 75:654–662PubMed
22.
Zurück zum Zitat Andreassen TT, Ejersted C, Oxlund H (1999) Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960–968CrossRefPubMed Andreassen TT, Ejersted C, Oxlund H (1999) Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960–968CrossRefPubMed
23.
Zurück zum Zitat Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA (1999) Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop 366:258–263CrossRefPubMed Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA (1999) Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop 366:258–263CrossRefPubMed
24.
Zurück zum Zitat Kim HW, Jahng JS (1999) Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J 19:71–77PubMed Kim HW, Jahng JS (1999) Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J 19:71–77PubMed
25.
Zurück zum Zitat Andreassen TT, Fledlius C, Ejersted C, Oxlund H (2001) Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 72:304–307PubMedCrossRef Andreassen TT, Fledlius C, Ejersted C, Oxlund H (2001) Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 72:304–307PubMedCrossRef
26.
Zurück zum Zitat Bonnarens F, Einhorn TA (1984) Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2:97–101CrossRefPubMed Bonnarens F, Einhorn TA (1984) Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2:97–101CrossRefPubMed
27.
Zurück zum Zitat Waynforth HB (1980) Experimental and surgical techniques in the rat. Academic Press, New York, pp 161–163 Waynforth HB (1980) Experimental and surgical techniques in the rat. Academic Press, New York, pp 161–163
28.
Zurück zum Zitat Müller W (1975) A method for the comparison of morphometrical data on skeletal muscles in young rats of different ages and body weights. Histochemistry 43:241–248CrossRefPubMed Müller W (1975) A method for the comparison of morphometrical data on skeletal muscles in young rats of different ages and body weights. Histochemistry 43:241–248CrossRefPubMed
29.
Zurück zum Zitat Giannoudis P, Tzioupis C, Almali T, Buckley R (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38(suppl 1):S90–S99CrossRefPubMed Giannoudis P, Tzioupis C, Almali T, Buckley R (2007) Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 38(suppl 1):S90–S99CrossRefPubMed
30.
Zurück zum Zitat Melhus G, Solberg LB, Dimmen S, Madsen JE, Nordsletten L, Reinholt FP (2007) Experimental osteoporosis induced by ovariectomy and vitamin D deficiency does not markedly affect fracture healing in rats. Acta Orthop 78:393–403CrossRefPubMed Melhus G, Solberg LB, Dimmen S, Madsen JE, Nordsletten L, Reinholt FP (2007) Experimental osteoporosis induced by ovariectomy and vitamin D deficiency does not markedly affect fracture healing in rats. Acta Orthop 78:393–403CrossRefPubMed
31.
Zurück zum Zitat Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD, Diamond T (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28:80–86CrossRefPubMed Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD, Diamond T (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28:80–86CrossRefPubMed
32.
Zurück zum Zitat Yingje H, Ge Z, Yishen W, Ling Q, Hung WY, Kwoksui L, Fuxing P (2007) Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 41:631–638CrossRef Yingje H, Ge Z, Yishen W, Ling Q, Hung WY, Kwoksui L, Fuxing P (2007) Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 41:631–638CrossRef
33.
Zurück zum Zitat Wang JW, Li W, Xu SW, Yang DS, Wang Y, Lin M, Zhao GF (2005) Osteoporosis influences the middle and late periods of fracture healing in a rat osteoporotic model. Chin J Traumatol 8:111–116PubMed Wang JW, Li W, Xu SW, Yang DS, Wang Y, Lin M, Zhao GF (2005) Osteoporosis influences the middle and late periods of fracture healing in a rat osteoporotic model. Chin J Traumatol 8:111–116PubMed
34.
Zurück zum Zitat McCann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 3:384–393CrossRef McCann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 3:384–393CrossRef
35.
Zurück zum Zitat Stürmer EK, Seidlová-Wuttke D, Sehmisch S, Rack T, Wille J, Frosch KH, Wuttke W, Stürmer KM (2006) Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone and raloxifene. J Bone Miner Res 21:89–96CrossRefPubMed Stürmer EK, Seidlová-Wuttke D, Sehmisch S, Rack T, Wille J, Frosch KH, Wuttke W, Stürmer KM (2006) Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone and raloxifene. J Bone Miner Res 21:89–96CrossRefPubMed
36.
Zurück zum Zitat Tezval M, Stuermer EK, Sehmisch S, Rack T, Stary A, Stebener M, Konietschke F, Stuermer KM (2009) Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur. Osteoporos Int. [Epub ahead of print]. doi:10.1007/s00198-009-0941-y Tezval M, Stuermer EK, Sehmisch S, Rack T, Stary A, Stebener M, Konietschke F, Stuermer KM (2009) Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur. Osteoporos Int. [Epub ahead of print]. doi:10.​1007/​s00198-009-0941-y
37.
Zurück zum Zitat Kubo T, Shiga T, Hashimoto J (1999) Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet. J Steroid Biochem Mol Biol 68:197–202CrossRefPubMed Kubo T, Shiga T, Hashimoto J (1999) Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet. J Steroid Biochem Mol Biol 68:197–202CrossRefPubMed
38.
Zurück zum Zitat Schmidmaier G, Wildemann B, Melis B, Krummrey G, Einhorn A, Haas N, Raschke M (2004) Development and characterization of a standard closed tibial fracture model in the rat. Eur J Trauma 30:35–42CrossRef Schmidmaier G, Wildemann B, Melis B, Krummrey G, Einhorn A, Haas N, Raschke M (2004) Development and characterization of a standard closed tibial fracture model in the rat. Eur J Trauma 30:35–42CrossRef
39.
Zurück zum Zitat Hadjiargyrou M, Lambardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT (2002) Transcriptional profiling of bone regeneration: insight into the molecular complexity of wound repair. J Biol Chem 277:30177–30182CrossRefPubMed Hadjiargyrou M, Lambardo F, Zhao S, Ahrens W, Joo J, Ahn H, Jurman M, White DW, Rubin CT (2002) Transcriptional profiling of bone regeneration: insight into the molecular complexity of wound repair. J Biol Chem 277:30177–30182CrossRefPubMed
40.
Zurück zum Zitat Drosse I, Volkmer E, Seitz S, Seitz H, Penzkofer R, Zahn K, Matis U, Mutschler W, Augat P, Schieker M (2008) Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: a biomechanical, veterinary and trauma surgical perspective. Tissue Eng Part C Methods 1:79–88CrossRef Drosse I, Volkmer E, Seitz S, Seitz H, Penzkofer R, Zahn K, Matis U, Mutschler W, Augat P, Schieker M (2008) Validation of a femoral critical size defect model for orthotopic evaluation of bone healing: a biomechanical, veterinary and trauma surgical perspective. Tissue Eng Part C Methods 1:79–88CrossRef
41.
Zurück zum Zitat Mark H, Rydevik B (2005) Torsional stiffness in healing fractures: influence of ossification: an experimental study in rats. Acta Orthop 3:428–433 Mark H, Rydevik B (2005) Torsional stiffness in healing fractures: influence of ossification: an experimental study in rats. Acta Orthop 3:428–433
42.
Zurück zum Zitat Hill EL, Kraus K, Labierre KP (1995) Ovariectomy impairs fracture healing after 21 days in rat. Trans Orthop Res Soc 20:230 Hill EL, Kraus K, Labierre KP (1995) Ovariectomy impairs fracture healing after 21 days in rat. Trans Orthop Res Soc 20:230
43.
Zurück zum Zitat Tsahakis PJ, Martin DF, Harrow ME, Kiebzak GM, Meyer RA Jr (1996) Ovariectomy impairs femoral fracture healing in adult female rats. Trans Orthop Res Soc 21:264 Tsahakis PJ, Martin DF, Harrow ME, Kiebzak GM, Meyer RA Jr (1996) Ovariectomy impairs femoral fracture healing in adult female rats. Trans Orthop Res Soc 21:264
44.
Zurück zum Zitat Walsh WR, Sherman P, Howlet CR, Sonnabend DH, Ehrlich MG (1997) Fracture healing in a rat osteopenia model. Clin Orthop 342:218–227PubMed Walsh WR, Sherman P, Howlet CR, Sonnabend DH, Ehrlich MG (1997) Fracture healing in a rat osteopenia model. Clin Orthop 342:218–227PubMed
45.
Zurück zum Zitat Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA (2008) Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 90(suppl 1):120–127CrossRefPubMed Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA (2008) Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 90(suppl 1):120–127CrossRefPubMed
46.
Zurück zum Zitat Komatsu DE, Brune KA, Liu H, Schmidt AL, Han B, Zeng QQ, Yang X, Nunes JS, Lu Y, Geiser AG, Ma YL, Wolos JA, Westmore MS, Sato M (2009) Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 4:1570–1579 Komatsu DE, Brune KA, Liu H, Schmidt AL, Han B, Zeng QQ, Yang X, Nunes JS, Lu Y, Geiser AG, Ma YL, Wolos JA, Westmore MS, Sato M (2009) Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 4:1570–1579
47.
Zurück zum Zitat Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 11:2038–2047CrossRef Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res 11:2038–2047CrossRef
48.
Zurück zum Zitat Brennan TC, Rizzoli R, Ammann P (2009) Selective modification of bone quality by PTH, pamidronate or raloxifene. J Bone Miner Res 24:800–808CrossRefPubMed Brennan TC, Rizzoli R, Ammann P (2009) Selective modification of bone quality by PTH, pamidronate or raloxifene. J Bone Miner Res 24:800–808CrossRefPubMed
Metadaten
Titel
Strontium Ranelate Enhances Callus Strength More Than PTH 1-34 in an Osteoporotic Rat Model of Fracture Healing
verfasst von
Bjoern Habermann
Konstantinos Kafchitsas
Gavin Olender
Peter Augat
Andreas Kurth
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 1/2010
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-009-9317-8

Weitere Artikel der Ausgabe 1/2010

Calcified Tissue International 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.